Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches
暂无分享,去创建一个
P. Brennan | L. Simonato | I. Holcatova | P. Lagiou | M. Foll | J. McKay | C. Canova | D. Anantharaman | J. Polesel | B. Abedi-Ardekani | Sandra Perdomo | M. Vilensky | P. Avogbe | F. Calvez-Kelm | Priscilia Chopard | Violeta Lescher Facciolla | J. Mckay | P. Chopard | P. Brennan
[1] M. J. Peebles. Relationship , 2020, Definitions.
[2] K. Maclennan,et al. The genomic road to invasion—examining the similarities and differences in the genomes of associated oral pre-cancer and cancer samples , 2017, Genome Medicine.
[3] M. Berger,et al. The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform , 2017, JAMA oncology.
[4] P. Brennan,et al. KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control , 2016, Oncotarget.
[5] Ryan D. Morin,et al. Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies , 2016, Molecular Cancer Research.
[6] Ahmet Zehir,et al. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. , 2016, The New England journal of medicine.
[7] M. Olivier,et al. Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer , 2016, EBioMedicine.
[8] O. Harismendy,et al. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients , 2016, Clinical Cancer Research.
[9] Scott R. Kennedy,et al. Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues , 2016, Proceedings of the National Academy of Sciences.
[10] H. Bai,et al. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer , 2016, Oncotarget.
[11] Subhajyoti De,et al. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection , 2016, Nucleic acids research.
[12] G. Gatta,et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. , 2015, European journal of cancer.
[13] P. Campbell,et al. Somatic mutation in cancer and normal cells , 2015, Science.
[14] Hui Yang,et al. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR , 2015, Nature Protocols.
[15] J. Ptak,et al. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord , 2015, Proceedings of the National Academy of Sciences.
[16] R. Scharpf,et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients , 2015, Nature Communications.
[17] K. Kinzler,et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas , 2015, Science Translational Medicine.
[18] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[19] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[20] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[21] K. Kinzler,et al. Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies , 2014 .
[22] V. Servois,et al. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma , 2014, International journal of cancer.
[23] Antonio C. Wolff,et al. Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer , 2014, Clinical Cancer Research.
[24] Ash A. Alizadeh,et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.
[25] F. Mouliere,et al. Circulating cell free DNA: Preanalytical considerations. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[26] W. Ahrens,et al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. , 2013, Journal of the National Cancer Institute.
[27] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[28] D. Wong,et al. Salivary biomarker development using genomic, proteomic and metabolomic approaches , 2012, Genome Medicine.
[29] N. Rosenfeld,et al. Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA , 2012, Science Translational Medicine.
[30] William Wheeler,et al. Detectable clonal mosaicism and its relationship to aging and cancer , 2012, Nature Genetics.
[31] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[32] P. Liaw,et al. Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus , 2011, Journal of thrombosis and haemostasis : JTH.
[33] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[34] P. Brennan,et al. Alcohol and tobacco, and the risk of cancers of the upper aerodigestive tract in Latin America: a case–control study , 2011, Cancer Causes & Control.
[35] B. Takkouche,et al. Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis. , 2009, European journal of oral sciences.
[36] W. Ahrens,et al. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[37] Joakim Dillner,et al. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV‐associated cancers , 2008, International journal of cancer.
[38] P. Csermely,et al. Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases , 2008, Current genomics.
[39] M. Olivier,et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.
[40] F. Clavel-Chapelon,et al. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. , 2006, Cancer research.
[41] M. Pancorbo,et al. Use of cytological specimens for p53 gene alteration detection in oral squamous cell carcinoma risk patients. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[42] S. Franceschi,et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.
[43] S. Liu,et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] S. Goodman,et al. Circulating mutant DNA to assess tumor dynamics , 2008, Nature Medicine.
[45] M. Fleischhacker,et al. Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.
[46] F. A. Benko,et al. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. , 1997, British Journal of Cancer.